Position
Executive Vice President
Company
Allogene Therapeutics, Inc.
San FranciscoBiotechnologyHealth CareTherapeuticsDescription
On August 31, 2026, Allogene Therapeutics, Inc. announced the retirement of Geoffrey Parker, the Executive Vice President and Chief Financial Officer. His retirement will be effective on November 6, 2026
Quick answer
Allogene Therapeutics Announces Retirement of CFO Geoffrey Parker (September 2, 2026). Allogene Therapeutics, Inc. is based in San Francisco, California, United States.
- What did Allogene Therapeutics, Inc. announce on September 2, 2026?
- On August 31, 2026, Allogene Therapeutics, Inc. announced the retirement of Geoffrey Parker, the Executive Vice President and Chief Financial Officer.
- What does Allogene Therapeutics, Inc. do?
- Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer.
- Where is Allogene Therapeutics, Inc. based?
- Allogene Therapeutics, Inc. is based in San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Foventa Therapeutics (September 2, 2026), Vertex Pharmaceuticals (September 2, 2026), Eikon Therapeutics (September 3, 2026) and Arletta Pharma Solutions (September 1, 2026) also announced leadership changes within 45 days of Allogene Therapeutics, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Foventa Therapeutics Appoints Dr Zaiba Malik as Chief Medical Officer and Julia Jones as Chief Financial Officer (September 2, 2026)
- Vertex Pharmaceuticals Appoints Jonathan Poole as Chief Financial Officer (September 2, 2026)
- Eikon Therapeutics Appoints Ching-Pin Chang as Chief Scientific Officer (September 3, 2026)
- Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer (September 1, 2026)
- Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer (September 1, 2026)
- Priothera Appoints Nigel Clark as Chief Business Officer (September 3, 2026)
Who to call at Allogene Therapeutics, Inc., and when
A new leader at Allogene Therapeutics, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Allogene Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Allogene Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Allogene Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Allogene Therapeutics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Allogene Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.